Spravato is a brand-name treatment for depression but is only used when other drugs and therapies don’t work, or there’s a high risk of suicide. The FDA has approved its use because esketamine, its active ingredient, rapidly improves depression symptoms in some people. Spravato is not a typical prescription drug that people can take home. Instead, its administration is supervised and monitored by a healthcare professional in a certified clinic. It not only requires a prescription but approval by the manufacturer’s safety (REMS) program.
Check our best Spravato (84 MG Dose) prices
Spravato
Esketamine
Treats, along with an oral antidepressant, treatment-resistant depression (TRD) and major depressive disorder (MDD) with acute suicidal ideation or behavior.
Antidepressant augmentation agent, central nervous system depressant, dissociative hallucinogen, NMDA receptor antagonist
Nasal spray
Into the nose
The FDA has approved Spravato as an adjunct treatment for treatment-resistant major depressive disorder (MDD) and moderate to severe MDD when there’s a high risk of suicide.
Nasal spray
28 mg per device
Spravato is only administered by healthcare professionals in a clinical setting.
For treatment-resistant depression in adults: 56 mg initial dose followed by:
56–84 mg twice weekly for four weeks
56–84 mg once weekly for the next four weeks
56–84 mg once every two weeks starting in the ninth week of treatment
For major depressive disorder with acute suicidality in adults:
56–84 mg twice weekly for four weeks
Spravato (84 MG Dose)
28mg/device solution therapy pack
You must first enroll in the Risk Evaluation and Mitigation Strategies (REMS) program set up for this medication.
Spravato is only administered in a monitored and certified clinical setting with a healthcare professional in attendance. The entire process may take two hours or longer.
Keep all appointments.
Follow all the instructions given by the clinic’s healthcare providers before, during, and after treatment.
A healthcare professional will instruct you on how to administer doses and supervise the administration of the drug. Follow these instructions.
You are released only after an assessment. The clinic may make you stay longer for continued monitoring.
You must arrange for transportation following treatment. The clinic may not release you until a ride has arrived.
Do not miss treatment sessions.
If a treatment session is missed:
The therapist usually resumes treatment if depression symptoms haven’t worsened.
The therapist may restart treatment from day one if depression symptoms have worsened.
This medicine is not right for everyone.
A doctor or other healthcare professional will not use it in people with:
Known allergies to esketamine or ketamine
A history of aneurysms
Abnormal connections between arteries and veins
A history of bleeding in the brain
Patients must enroll in a Risk Evaluation and Mitigation Strategies program before Spravato can be administered. Fill this form out honestly. It will ask for information vital to ensuring your safety.
A healthcare provider must assess your health before and after each treatment. Regular visits are required to monitor the effectiveness of therapy and spot any potential side effects. Keep all appointments.
Tell the prescribing doctor if you are pregnant, breastfeeding, or have:
A history of bleeding in the brain
Blood vessel problems
High blood pressure
A history of heart attack
Heart valve disease
Slow heartbeats
A history of stroke
A history of brain injury
Liver problems
Any past incidents of psychosis (hallucinations or delusions)
Any history of drug or alcohol abuse
Esketamine can cause serious problems, including:
Prolonged sedation and impairment
Respiratory depression (slow or inadequate breathing)
Increased risk of suicidal thoughts or actions
Dissociation (feeling separated from yourself or the world)
Hallucinations
Fear and anxiety
Temporary cognitive impairment
Increased blood pressure
It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. Use an effective form of birth control to keep from getting pregnant during treatment with this medicine.
Do not breastfeed during treatment with this medicine.
This medicine may make you drowsy, confused, or have problems with thinking clearly. Do not drive or do any potentially hazardous activities until the next day after a restful sleep. You will need someone to drive you home after treatment with this medicine.
Esketamine has a high potential for addiction and abuse. An overdose can be fatal. Talk to the prescribing healthcare professional if you develop cravings for the drug or the treatment.
Make sure the healthcare professional treating you knows about all the prescription drugs, over-the-counter medications, supplements, and off-label drugs that you are using, particularly:
Drugs that make you sleepy such as narcotic pain medications, benzodiazepines, sleeping pills, alcohol, marijuana products, and similar drugs
Stimulants such as amphetamines, wakefulness agents, and ADHD medications
Monoamine oxidase inhibitors (find a list of MAO inhibitors here)
Illicit drugs
If you need to take a nasal steroid or decongestant, take your dose at least one hour before your Spravato treatment session.
Serious side effects
Many of the serious side effects of esketamine occur during a treatment session. Tell the attending healthcare provider about any problems you experience during a treatment session, including:
Confusion about identity, place, and time
Hallucinations
Anxiety, agitation, irritability, restlessness, panic attacks
Trouble thinking
Trouble breathing, chest pain
Sudden, severe headache, vision changes, seizures, loss of consciousness, memory loss
Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
Tell the prescriber about any signs or symptoms of a possible serious side effect that occur after a treatment session, including:
Thoughts of hurting yourself, suicide attempts, worsening depression, unusual changes in mood or behavior
Prolonged drowsiness or sleepiness
Less serious side effects
Drowsiness
Dizziness
Nausea
Vertigo
Taste changes
Numbness
Anxiety
Low energy
Spravato drug summary, Prescriber’s Digital Reference (PDR)
Spravato esketamine hydrochloride solution prescribing information, DailyMed (NIH National Library of Medicine)
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados